CSATVB Conferences
For the Summit Program (click here).
Note: All Summit Program times are in EDT.
2020 CANADIAN VASCULAR & LIPID SUMMIT
Joint symposia of Canadian Lipoprotein Conference and the
Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology
VIRTUAL MEETING
Thursday, October 15th - Friday, October 16th, 2020
Conference Chairs: Catherine Martel and Robert (Scott) Kiss
Time is in EDT (Montreal)
Click Here for PDF
2020 Lectureships and Awards
- CLC Amgen Stewart Whitman Young Investigator Award Lecture: Dr. Erin Mulvihill, Director, Energy Substrate Metabolism Research Laboratory, University of Ottawa Heart Institute; Assistant Professor, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Canada
- Simon Pierre Noel Lecture: Dr. Vincent Poitout, Scientific Director, CR-CHUM; Canada Research Chair in Diabetes and Pancreatic β-cell Function; Professor, Department of Medicine, Université of Montreal, Montreal, Canada
- Clinical Scientist Lecture: Dr. Sophie Bernard, Director, Genetic Dyslipidemias Clinic, IRCM; Associate Professor, Department of Medicine, Université of Montreal, Endocrinologist, CHUM, Montreal, Canada
- Rubinstein Lecture: Dr. Karin Bornfeldt, Professor, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, USA
- CIHR-ICRH Distinguished Lecturer/CSATVB Scientific Excellence Award in Blood and Blood Vessel Sciences: Dr. Philip Wells, Professor, Chair and Chief, Department of Medicine, The University of Ottawa, Faculty of Medicine and The Ottawa Hospital Senior Scientist, Ottawa Hospital Research Institute, Canada
- 2020 CLC Amgen Stewart Whitman Young Investigator Award
- 2020 Yves Marcel Established Investigator Award
THURSDAY, OCTOBER 15, 2020
CSATVB Business meeting
10.00am – 12.00pm
Trainee Workshop (CSATVB, CLC & CIHR/ICRH)
12.00pm – 3.00pm (20 min. presentation + 10 min. questions)
12.00pm – 12.30pm How to find a suitable postdoctoral position?
Erin Mulvill, Assistant Professor, U of Ottawa Heart Institute
12.30pm – 1.00pm From a faculty position to industry
Nic Bousette, Medical Science Liaison, Merck
1.00pm – 1.30pm Do I have what it takes to have my own start-up?
Steve Poirier, CEO, MONOGENIC Pharmaceuticals
1.30pm – 2.00pm How to become independent: starting your own lab without competing with your former PI?
Mireille Ouimet, Assistant Professor, U of Ottawa Heart Institute
2.00pm – 2.30pm I am a PhD doing clinical studies: a translational story
Benoit Arsenault, Assistant Professor, U Laval
2.30pm – 3.00pm How to optimise your CV to go in industry while completing your PhD or PDF
Andreea Milasan, Medical Science Liaison, Novartis
Moderated short talk session (individual links)
3.00pm – 5.00pm
(5 min. live presentation + 5 min. for questions)
Session I: Inflammation in the blood vessel wall
5.00pm – 7.30pm
5.00pm – 5.50pm 2020 CLC Rubenstein Lecture
Karin Bornfeldt, University of Washington, Seattle, USA
Apolipoprotein C3 and mechanisms of cardiovascular complications of type 1 diabetes
5.50pm – 6.10pm Sumayyah Sokeechand, PhD candidate at McMaster University
IL-15Rα deficiency reduces atherosclerotic plaque development in apoE-/- mice
6.10pm – 6.40pm Warren Lee, University of Toronto, St. Michael’s, Ontario, Canada
LDL transcytosis and the initiation of atherosclerosis - a role for nuclear HMGB1
6.40pm – 7.00pm Adil Rasheed, Postdoctoral Fellow at the Ottawa Heart Institute
Loss of the mixed lineage kinase domain-like protein decreases necrotic core but increases
macrophage lipid accumulation in atherosclerosis
7.00pm – 7.30pm Goo Taeg Oh (KoSLA), Ewha Womans University, Seoul, Korea
Atheroprotective roles of myeloid cells in the pathogenesis of atherosclerosis
FRIDAY, OCTOBER 16, 2020
CSATVB Annual General Meeting meeting (all welcome)
10.00am – 11.00am
CLC Business meeting
11.00am – 12.00pm
Session II: CSATVB Presidents Symposium
12.00pm – 13.00pm
12.00pm – 12.10pm CIHR-ICRH Distinguished Lecturer/CSATVB Scientific Excellence Award in Blood and Blood Vessel Sciences – Presentation by Dr. Brian Rowe, ICRH Scientific Director
12.10pm – 13.00pm Philip Wells, Ottawa Hospital Research Institute, Ontario, Canada
Is there an association between venous and arterial thrombosis?
Session III: Genetic Dyslipidemias in Canada
1.00pm – 3.30pm
1.00pm – 1.30pm Jacques Genest, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
Lipid Genetics 2020 Vision: Genetic Testing for Lipoprotein disorders in Canada
1.30pm – 1.50pm Danielle Alvares, PhD candidate at University of Toronto
Role of bile acids in hepatic lipid metabolism: characterization of the fasting lipid and lipoprotein profile of Tgr5-/- hamsters
1.50pm – 2.10pm Mark Trinder, MD/PhD candidate at UBC
Genetic and pharmacological inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol levels during sepsis and improves survival.
2.40pm – 3.00pm Vatsal Sachan, PhD candidate at IRCM
The proprotein convertase PC7 regulates hepatic apolipoprotein B levels and triglyceride metabolism
3.00pm – 3.30pm 2020 Clinician Scientist Award
Sophie Bernard, IRCM, Montreal, Canada
Spectrum of chylomicronemia from familial to oligogenic and polygenic multifactorial syndromes
Session IV: Diabetes & Lipid metabolism
4.00pm – 7.30pm
4.00pm – 4.30pm Simon Pierre Noel Lecture
Vincent Poitout, CR-CHUM, Montreal, Quebec, Canada
Fatty-acid receptors and pancreatic islet function
4.30pm – 4.50pm Shaza Asif, MSc candidate at U of Ottawa Heart Institute
Investigating the metabolic benefits of intermittent fasting-induced ketogenesis in a non-
alcoholic fatty liver disease mouse model
4.50pm – 5.10pm Jihong Lian, Postdoctoral Fellow at the University of Alberta
Arylacetamide deacetylase (AADAC), a new player in hepatic lipid homeostasis
5.10pm – 5.40pm Pedro Geraldes, U Sherbrooke, Quebec, Canada
New treatment strategies to prevent peripheral arterial disease in diabetes
5.40pm – 6.00pm Raquel Lunardi Baccetto, PhD candidate at the University of Saskatchewan
The role of NRF1 and NRF2 against fatty liver disease
6.00pm – 6.20pm Mateusz M. Tomczyk, PhD candidate at the University of Manitoba
SIRT3 attenuates doxorubicin induced cardiotoxicity by regulating the mitochondrial acetylome and cardiac lipidome
6.20pm – 6.40pm Clément Mercier, Postdoctoral Fellow at the Université de Sherbrooke
Deletion of SHP-1 in smooth muscle cells prevented diabetes-impaired collateral vessel formation in ischemic muscle
6.40pm – 7.00pm 2019 CLC Amgen Stewart Whitman Young Investigator Award Lecture
Erin Mulvihill, U of Ottawa Heart Institute, Ontario, Canada
Dissecting the action of Dipeptidyl-Peptidase 4 in Hepatic and Intestinal Lipid Metabolism
7.00pm – 7.30pm Vascular & Lipid Summit Award Presentations
Students/PDFs Short Presentation Awards
Students/PDFs Presentation Awards
2020 CLC Amgen Stewart Whitman Young Investigator Award
2020 Yves Marcel Established Investigator Award